A Study of Ramucirumab or Icrucumab in Colorectal Cancer

Clinical trial NCT01111604 · COMPLETED

Trial details

NCT number: NCT01111604
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Colon Cancer Rectal Cancer

Start date: 2010-08-01
Primary completion: 2013-12-01
Enrollment: 158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.